Owners and management
CVR: 46681657
Not available
Nordic Cell Therapy Group Holding ApS (100%)
CVR · view owners
Juan Carlos Villaescusa Ramirez, Michael Wagner Christiansen
CVR · view management
Active
Founded 6 August 2026
CVR · view overview
No headcount reported
Name registered: Corcellys Therapeutics ApS
CVR · 06/08/2026
View the full event history
Corcellys Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Juan Carlos Villaescusa Ramirez and Michael Wagner Christiansen. The company is owned by Nordic Cell Therapy Group Holding ApS.
Selskabets formål er at drive virksomhed med forskning i, udvikling og kommercialisering af lægemidler, terapeutiske produkter, teknologier og immaterielle rettigheder inden for bioteknologi, herunder celleterapi, samt enhver i forbindelse hermed stående virksomhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Corcellys Therapeutics ApS is 46681657.
Corcellys Therapeutics ApS is owned by Nordic Cell Therapy Group Holding ApS.
The management of Corcellys Therapeutics ApS consists of Juan Carlos Villaescusa Ramirez and Michael Wagner Christiansen.
Corcellys Therapeutics ApS was founded on 6 August 2026.
Corcellys Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
corcellys.com belongs to Corcellys Therapeutics ApS, CVR number 46681657.
Claim this page to add your logo and social links. Free to get started.
Address changed to Ole Maaløes Vej 3, 2200 København N (August 22, 2026).
Contact info changed: new phone: 25127676, new email: [email protected], new website: www.corcellys.com (August 22, 2026).
As of August 6, 2026, Juan Carlos Villaescusa Ramirez is registered as director of Corcellys Therapeutics ApS.
As of August 6, 2026, Michael Wagner Christiansen is registered as director of Corcellys Therapeutics ApS.
As of August 6, 2026, Nordic Cell Therapy Group Holding ApS is registered as an owner of Corcellys Therapeutics ApS with an ownership share of 100%.
Corcellys Therapeutics ApS was founded on August 6, 2026.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
